The activation of SPANX-N3 can be achieved through various biochemical pathways that enhance its functional activity within the cell. One such mechanism involves the increase of intracellular cAMP levels, a pivotal second messenger in numerous signaling cascades. The elevation of cAMP can result from the activation of adenylate cyclase or inhibition of phosphodiesterases, leading to the subsequent activation of protein kinase A (PKA). Once activated, PKA may phosphorylate SPANX-N3, which is a post-translational modification that typically serves to regulate protein function. This cascade can be triggered by agents that either directly stimulate adenylate cyclase or block the degradation of cAMP. Additionally, agents that mimic the action of cAMP can directly activate PKA, thus bypassing upstream receptors and G-proteins, offering another route to enhance SPANX-N3 activity.
Another avenue for SPANX-N3 activation is through modulation of intracellular calcium levels. Calcium serves as a universal signaling molecule, and its concentration within the cell is finely controlled. Compounds that act as ionophores or agonists at calcium channels alter the calcium influx, leading to the activation of calcium-dependent protein kinases. These kinases can then target numerous proteins, potentially including SPANX-N3, for phosphorylation, thereby increasing their activity. Moreover, the activation of PKC, a family of kinases responsive to diacylglycerol and increased intracellular calcium, can also result in the phosphorylation of proteins involved in diverse cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, which increases intracellular cAMP levels, leading to activation of protein kinase A (PKA). PKA can phosphorylate SPANX-N3, enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate substrates that might include SPANX-N3 or modulate its activity through downstream signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that might phosphorylate SPANX-N3, thereby increasing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic receptor agonist that leads to increased intracellular cAMP and subsequent PKA activation, potentially enhancing the phosphorylation of SPANX-N3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that permeates cell membranes and directly activates PKA, which could phosphorylate SPANX-N3 and increase its functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent kinases that may phosphorylate SPANX-N3. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Activates G protein-coupled histamine receptors that can increase intracellular calcium or cAMP, indirectly leading to the activation of kinases that may phosphorylate SPANX-N3. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
cAMP analog that activates PKA, which can then phosphorylate SPANX-N3, potentially enhancing its activity. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
L-type calcium channel agonist that increases calcium influx, possibly activating calcium-dependent protein kinases that may increase SPANX-N3 activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Activates beta-adrenergic receptors, leading to increased cAMP and activation of PKA, which could phosphorylate and activate SPANX-N3. | ||||||